Background {#Sec1}
==========

Ectopic pregnancy is the leading cause of maternal morbidity and mortality during the first trimester and the incidence increases dramatically with assisted reproductive technology (ART), occurring in approximately 1.5--2.1% of patients undergoing IVF \[[@CR1], [@CR2]\]. The majority of ectopic pregnancies from either IVF or spontaneous pregnancy occur within the fallopian tubes, but implantation may occur in other locations such as the cervix, ovary, or abdomen \[[@CR3]\]. Abdominal ectopic pregnancies are a very rare form of ectopic pregnancy, yet are clinically significant due to their potential for high morbidity and often atypical presentation \[[@CR4]\].

Recent studies have attempted to identify risk factors for ectopic pregnancy after IVF. Suggested risk factors include infertility due to tubal factor, endometriosis, transfer at blastocyst stage, higher number of embryos transferred, decreased endometrial thickness, variation in culture media, and fresh embryo transfer \[[@CR5]--[@CR9]\]. However, very little data exists regarding risk factors for abdominal ectopic pregnancy after IVF.

In this case study, we report an abdominal ectopic pregnancy after IVF with fresh single embryo transfer. We also performed a systematic review of the literature for known cases of abdominal ectopic pregnancy after IVF and provide detailed characterization of these patients and risk factors for this rare complication.

Case description {#Sec2}
----------------

The patient was a 30-year-old G2P0010 who presented to our fertility center seeking fertility treatment. She had a medical history of polycystic ovarian syndrome (PCOS) and her partner had a diagnosis of male factor infertility. She had no prior surgical history, no known allergies, and medications included prenatal vitamins. She denied any history of sexually transmitted infections and had a normal hysterosalpingogram and saline sonohysterogram. Her first IVF cycle with an elective single embryo transfer resulted in a negative pregnancy test. Her second IVF cycle used a GnRH antagonist stimulation protocol and she was triggered with Ovidrel on stimulation day 12. Twenty-two oocytes were retrieved. On day five a single fresh blastocyst was transferred using a pass through technique under ultrasound guidance. A stiff outer sheath was introduced through the cervix and past the internal os. A soft tipped catheter containing the embryo was advanced through the outer sheath and the embryo was expelled into the uterine cavity approximately 1.5 cm from the uterine fundus with good visualization. Beta hCG was positive on post-transfer day 9 and serial beta hCG values were monitored and continued to rise appropriately (Table [1](#Tab1){ref-type="table"}). On day 28 after embryo transfer, the patient underwent a transvaginal ultrasound (TVUS) in the office that did not identify an intrauterine pregnancy (IUP) or any abnormal adnexal structures. She was asymptomatic with no vaginal bleeding or abdominal pain. The patient was sent for a more comprehensive ultrasound evaluation at the associated Maternal Fetal Medicine unit and another beta hCG value was obtained. Repeat scan similarly failed to identify an IUP or visualize an ectopic pregnancy. The beta hCG was 12,400 pg/mL. Given the high beta hCG value in the absence of an IUP, the patient was counseled and advised to take methotrexate treatment for presumed ectopic pregnancy of unknown location. One day later (day 29), she received an intramuscular dose of 83 mg (50 mg/m^2^ body surface area) methotrexate with plans to follow up with repeat beta hCG and TVUS.Table 1Beta hCG level and timeline of eventsDayBeta HCG pg/mLEvent−5Oocyte retrieval, ICSI0Day 5 single embryo transfer928.71145.51313015382179911920202812,400Sac Check - No IUP or adnexal abnormalities2913,000Methotrexate given3220,00033TVUS - Right adnexal mass with gestational sac and fetal cardiac activity34Diagnostic laparoscopy - Abdominal ectopic

Four days after methotrexate administration, repeat beta hCG level continued to rise (20,000 pg/mL) and an ultrasound performed 1 day later demonstrated a right adnexal mass with a yolk sac, fetal pole, and fetal cardiac activity. The decision was made to proceed with diagnostic laparoscopy for treatment of ectopic pregnancy after failure of methotrexate therapy. The patient continued to be asymptomatic with no vaginal bleeding or abdominal pain. Diagnostic laparoscopy was performed on day 34 post-embryo transfer. The operative findings were significant for minimal hemoperitoneum (\<50 mL) and products of conception were noted to be implanted on the peritoneum of the posterior cul-de-sac medial to the left uterosacral ligament (Fig. [1](#Fig1){ref-type="fig"}). The products of conception were removed using graspers without difficulty and hemostasis was obtained with electrocautery and surgicel. All other pelvic organs including uterus and bilateral ovaries and tubes appeared grossly normal in appearance.Fig. 1Diagnostic laparoscopy demonstrating hemoperitoneum (*top image*) and products of conception implanted in the posterior cul-de-sac (*bottom image*)

Systematic review of the literature {#Sec3}
-----------------------------------

A systematic literature review was performed with the aim of identifying all other case reports of abdominal ectopic pregnancies after IVF. The literature search was performed using PubMed, Google Scholar, and EMBASE without language restriction encompassing publications until July 2016. Search terms used included 'IVF', 'ectopic pregnancy', 'abdominal ectopic pregnancy', and 'heterotopic pregnancy'. To the best of our knowledge, all reported cases and available data are summarized in Table [2](#Tab2){ref-type="table"}.Table 2Abdominal ectopic case reportsAuthor (year)Age/ParityInfertility etiologyOther pertinent historyPriorectopicStimulation ProtocolEgg \#ET no./timingFresh/Frozen ETMax HCG level (mIU/ml)Location (E/H)Stage at diagnosisRupture?InterventionOutcomeOehniger (1988) \[[@CR23]\]35 yo\
G0P0EndometriosisLaparotomy x 2, left salpingectomy, frozen pelvis; Right hydrosalpinx with partial obstructionNoFSH/Pergonal (hMG/hCG), hCG trigger44\
42--44 hFreshNASigmoid mesentery (E)\~41 days PTNoExploratory LaparotomyRemoval of pregnancy tissue by laparotomyBassil (1991) \[[@CR24]\]33 yo\
NAMale factorNANAClomid/hMG, hCG trigger64\
NAFreshNAPosterior uterus, broad ligament (H)19 weeks gestationNoLaparotomy, right adnexectomyDelivery of viable twins at 34 weeksFerland (1991) \[[@CR25]\]32 yo\
G4P0030DES exposure, secondary infertilityRight salpingectomy, left hydrosalpinxTubal ectopicLong protocol w/GnRH agonist73\
Day 2 ETFresh19,450Retroperitoneal (E)37 days PTYesLaparotomy, left salpingectomyRagni (1991) \[[@CR26]\]32 yo\
G1P0010Pelvic adhesive diseaseRight adnexectomy, hysteropexyTubal ectopicLong protocol w/GnRH agonist43\
Day 2 ETFreshNARight adnexa (H)12 weeks gestationNoSelective reduction of abdominal pregnancy, laparotomyLaparotomy for resorbing abdominal pregnancy, SAB of IUP at 16 weeksBalmaceda (1993) \[[@CR27]\]33 yo\
G3P1021TubalRight salpingectomy, left salpingostomyTubal Ectopic *x*2Short protocol, w/GnRH agonist154\
Day 4 ETFresh4651Abdominal - broad ligament (E)30 days PTNoLaparoscopy, salpingectomyLaparoscopic removal of abdominal ectopic, left salpingectomyFisch (1995) \[[@CR28]\]32 yo\
G2P0020TubalBilateral salpingectomyTubal ectopic *x*2Long protocol w/GnRH agonist53\
NAFreshNAIleum, left uterine cornua (H)10 weeks gestationYesGastrostoscopy, sigmoidoscopy, Tc scan, angiography, D&C, tagged RBC scan, LaparotomyLaparotomy for abdominal ectopic, D&C for incomplete AB of IUPDelRosario (1996) \[[@CR29]\]33 yo\
G1P1001TubalBreast CancerNoNANA4\
NAFrozen563Bladder (E)75 days PTYesMethotrexate, laparoscopyLaparoscopic removal of pregnancy tissueFisch (1996) \[[@CR11]\]38 yo\
G2P0020TubalLaparoscopic Salpingectomy *x*2, 8th IVF cycleTubal ectopic x 2Long protocol w/GnRH agonist144\
Day 3 ETFresh1730Broad Ligament (E)21 days PTYesExploratory LaparotomyRemoval of pregnancy tissue by laparotomyMoonen-Delarue (1996) \[[@CR30]\]23 yo\
G2P0020Pelvic adhesive diseaseRight salpingectomyTubal and abdominal ectopicNANANA\
NAFreshNAAbdominal - uterine fundus (E)28 weeksPlacental abruptionLaparotomyFetal demise of abdominal ectopic @ 28 weeksPisarska (1998) \[[@CR31]\]35 yo\
G2P0020UnexplainedNANoLong protocol w/GnRH agonist96\
NAFresh6004Bladder serosa (H)6 weeks gestationNoDiagnostic laparoscopyLaparoscopic removal of ectopic pregnancy (bladder), term delivery of IUPDeshpande (1999) \[[@CR32]\]33 yo\
G1P0010EndometriosisEndometriosis, left salpingectomy, Patent right tubeNoLong protocol w/GNRH agonist82\
Day 3 ETFresh55,560Twin pregnancy in broad ligament (H)7 weeks PTNoLaparotomyRemoval of twin ectopic pregnancy by laparotomy at 7 weeksScheiber (1999) \[[@CR33]\]37 yo\
G3P0030Tubal factor EndometriosisDORSalpingostomy, donor oocytesTubal ectopicNANA2\
Day 3 ETFrozenNAAbdominal (H)8.5 weeks PTNoKCl selective reduction of abdominal pregnancySelective reduction of abdominal pregnancy, full term viable IUPDmowski (2002) \[[@CR34]\]34 yo\
G0P0TubalBilateral SalpingectomyNoLong protocol w/GnRH agonist153\
Day 3 ETFresh38,635Retroperitoneal pancreatic (E)41 days PTYesLaparotomyRetroperitoneal subpancreatic ectopic removed by laparotomyJain (2002) \[[@CR35]\]29 yo\
G0P0UnexplainedNANoNANA2\
NANANAPouch of Douglas (H)9 weeks PTNALaparotomy at 4w weeks (no IUP seen), selective reduction of ectopic at 13 weeksSelective reduction of abdominal ectopic, removal by laparotomy, SAB of IUPCormio (2003) \[[@CR36]\]30 yo\
G2P0020TubalBilateral salpingectomyTubal ectopic *x*2Menotropins, hCG trigger74\
Day 3 ETFresh256,400Omentum, uterine fundus (H)13 weeks gestationNoLaparotomyLaparotomy for abdominal ectopic; Live IUP delivered at 36 weeksReid (2003) \[[@CR37]\]28 yo\
G5P1041Tubalbilateral salpingectomyTubal ectopic x3NANA3\
NANA5500Retroperitoneal, iliac bifurcation (E)63 days PTNALaparotomyRemoval of ectopic via laparotomyKitade (2005) \[[@CR38]\]37 yo\
G0P0UnexplainedNANoLong protocol w/GnRH agonist123\
Day 3 ETFresh45,896Splenic and Tubal (H)34 days PT (tubal), 46 day PT (splenic)Tubal - No, Splenic - Yes1) Laparoscopic salpingectomy 2) Exploratory laparotomyRemoval of tubal ectopic by laparoscopy, removal of splenic ectopic by laparotomy (12 days later)Ali (2006) \[[@CR39]\]35\
NATubalPelvic adhesionsNoNA111\
NAFresh1524Tube with Omental/peritoneal trophoblastic tissue (H)3 weeks PT - tubal ectopic; 5 weeks PT -- omental tissueNoLaparoscopic salpingectomy; Laparocopic removal of omental/peritoneal trophoblastic tissueRemoval of tubal and peritoneal/omental pregnancy tissue by 2 laparoscopiesApantaku (2006) \[[@CR40]\]33\
G3P1021TubalBilateral salpingectomyTubal ectopic *x*2NANA2\
NAFreshNARight adnexa (E)6 weeks PTNoLaparoscopyLaparoscopic removal of pregnancy tissueKnopman (2007) \[[@CR41]\]37 yo\
G4P0040UnexplainedNANoGnRH antagonist92\
Day 5 ETFresh1023Posterior cul-de-sac (H)7 weeks, nonviable IUP; 9 weeks ectopicYesLaparoscopyD&C for non-viable IUP; Laparoscopy for abdominal ectopicShih (2007) \[[@CR42]\]33 yo\
G0P0Male FactorPatent tubesNoLong protocol w/GnRH agonist4NA\
NAFresh901Cul-de-sac\
(E)28 days PTNoLaparoscopy converted to laparotomyRemoval of pregnancy tissue by laparotomyShojai (2007) \[[@CR43]\]35 yo\
G0P0Structural, DES exposureNANoNANA3\
NANANAAbdominal - uterine fundus (H)21 weeks gestationNoLaparotomyDelivery of viable twins at 32 weeksIwama (2008) \[[@CR44]\]31 yo\
G1P0010TubalRight Salpingectomy for tubal ectopic after IVF, left salpingectomy for hydrosalpinxTubal ectopicNANA3\
Day 3 ETFresh45, 369Inferior Vena Cava/Retroperitoneal (E)32 days PT: PUL; 53 days PT: retroperitoneal ectopicYesD&C, MTX, Diagnostic laparoscopy, repeat MTX, Exploratory laparotomyRuptured retroperitoneal ectopic, removed by laparotomyHyvarinen (2009) \[[@CR45]\]NA\
NANANANANANANA\
NANANAAbdominal (E)30 weeks gestationNoLaparotomyDelivery of viable fetus at 30 weeksZacche (2011) \[[@CR46]\]36\
G1P1TubalBilateral Salpingectomy, PIDNoNANA2\
NAFreshNAAbdominal (H)32 weeks at Cesarean DeliveryNoLaparotomy, hysterectomyViable twin pregnancies at 32 weeks; HysterectomyAngelova (2015) \[[@CR47]\]33\
NAMale FactorObturated left tubeNAShort protocol, w/GnRH antagonistNA2\
Day 3 ETFreshNAAbdominal - vesicouterine junction (E)23 days PTNoLaparoscopyLaparoscopic removal of pregnancy tissueDalmia (2015) \[[@CR48]\]37\
G1P0010EndometriosisTubal factorBilateral salpingectomy for hydrosalpinxNANANANA\
NANA21,730Left adnexa (E)2 weeks PTNoMini-laparotomyRemoval of ectopic via laparotomyKoyama (2015) \[[@CR49]\]32\
G5P1Male FactorNANoNANA1\
NAFrozen14,800Retroperitoneal (E)10 weeks gestationNALaparoscopyLaparoscopic removal of pregnancy tissue*Abbreviations*: *AB* Abortion, *D&C* Dilation and curettage, *DES* Diethylstilbestrol, *E* Ectopic, *FSH* Follicle stimulating hormone, *GnRH* Gonadotropin-releasing hormone, *H* Heterotopic, *hCG* Human chorionic gonadotropin, *hMG* Human menopausal gonadotropin, *HSG* Hysterosalpingogram, *IUP* Intrauterine pregnancy, *IVF* In vitro fertilization, *KCl* Potassium chloride, *MTX* Methotrexate, *NA* Not available, *PID* Pelvic inflammatory disease, *PT* Post transfer, *RBC* Red blood cell, *Tc* Technetium, *SAB* Spontaneous abortion

Results {#Sec4}
=======

A total of 28 cases of abdominal ectopic pregnancy after IVF were identified. The age of patients ranged from 23 to 38 yo (Mean = 33.2 S.D. = 3.2), with no age reported in 1 case. Infertility causes included tubal factor in 13 (46 %) cases, endometriosis in 4 (14 %) cases, male factor in 4 (14 %) cases, pelvic adhesive disease in 2 (7 %) cases, structural/DES exposure in 2 (7 %) cases, unexplained in 4 (14 %) cases, and one case did not specify the cause. Overall, anatomic/structural factors accounted for 17 (61 %) of the cases. A history of ectopic pregnancy was identified in 11 (39 %) cases. History of tubal surgery had been described in 14 (50 %) cases, 9 (32 %) of which were bilateral salpingectomy. Transfer of more than two embryos was reported in 15 (54 %) cases, two embryos were transferred in 7 (25 %) cases, while single embryo transfer was reported in only two (7 %) cases. No information about number of embryos transferred was available in 4 (14 %) cases. Fresh embryo transfer accounted for 20 (71 %) cases, frozen embryo transfer in 3 (11 %) cases, and 5 (18 %) cases did not specify fresh versus frozen embryo transfer. Heterotopic abdominal pregnancy occurred in 13 (46 %) cases, and 15 (54 %) were abdominal ectopic pregnancies. Notable cases include 5 retroperitoneal ectopic pregnancies, an abdominal fetal demise at 28 weeks, and 4 cases of viable abdominal pregnancies at 30 weeks, 32 weeks (two cases), and 34 weeks gestation.

Discussion {#Sec5}
==========

Abdominal ectopic pregnancies comprise less than 1 % of all ectopic pregnancies, yet have a maternal mortality rate eight times greater than tubal ectopic pregnancies \[[@CR10]\]. For this reason, early recognition and treatment is crucial in the setting of abdominal ectopic pregnancy. The case presented demonstrates the diagnostic challenge of abdominal ectopic, as the patient's beta hCG values followed a normal rise and the patient remained asymptomatic up to the point of diagnostic laparoscopy. Transvaginal ultrasound did not visualize the ectopic pregnancy until the beta hCG value was 20,000 pg/mL, which is far beyond the usual discriminatory zone. This atypical presentation of an ectopic pregnancy highlights the need to consider abdominal ectopic pregnancy in the differential of any pregnancy of unknown location after IVF, especially in the setting of non-diagnostic transvaginal ultrasound.

There appears to be an increased rate of ectopic pregnancies after ART when compared to rates in spontaneous pregnancy \[[@CR11]\]. As the number of IVF procedures performed continues to rise, the incidence of ectopic and abdominal ectopic pregnancy will likely also rise. While there are still relatively few reported cases of abdominal ectopic pregnancies after IVF, our systematic review demonstrates several trends among reported cases. First, the majority of cases (61 %) report a history of anatomic/structural infertility etiology with history of tubal factor infertility (TFI) (46 %) being the most common. This is consistent with TFI being a known risk factor for ectopic pregnancy following IVF. One study that examined the risk factors for EP following IVF in 712 women reported an odds ratio (OR) of 3.99 (95 % CI: 1.23 to 12.98) for women with TFI compared to those with other infertility causes \[[@CR12]\]. In a larger, more recent study of 553,577 ART cycles in the US, among all infertility diagnoses, TFI was the only one significantly associated with increased risk for ectopic pregnancy (adjusted relative risk (RR) 1.25, 95 % CI 1.16--1.35) \[[@CR13]\]. In addition, history of tubal ectopic pregnancy was particularly common, being reported in 37 % of the abdominal ectopic cases. This also appears to be consistent with the general ART-associated EP literature. A retrospective study that measured the risk of EP following IVF in 181 women with a previous ectopic demonstrated a 45-fold higher risk of recurrence when compared with 377 women with other causes of infertility. The authors reported that the prevalence of EP was 8.95 % compared with 0.75 % in the control group \[[@CR14]\]. History of prior tubal surgery was also particularly common (50 %) among abdominal ectopic cases in our systematic review. A history of tubal/pelvic surgery is another major risk factor for the development of EP following IVF. Odds ratio for developing EP was 8.52 (95 % CI: 5.91--12.27) for prior adnexal surgery, 11.02 (95 % CI: 5.49--22.15) for a previous tubal infertility surgery, 5.16 (95 % CI: 1.25--21.21) for prior surgery for endometriosis and 17.70 (95 % CI: 8.11--38.66) for a previous abdominal/pelvic surgery \[[@CR12], [@CR15], [@CR16]\]. Interestingly, bilateral salpingectomy was the most common tubal surgery reported in our case review. While the exact mechanism of abdominal ectopic after bilateral salpingectomy remains unclear, many authors have proposed that it may be due to the development of a micro-fistulous tract after salpingectomy. Uterine perforation during embryo transfer has also been suggested as a mechanism for abdominal ectopic pregnancy, and embryo transfer technique has been related to overall EP risk after IVF. Aspects of the transfer that may increase risk of EP include large volume of transfer media, induction of abnormal uterine contractions, and location of embryo transfer in relation to the uterine fundus \[[@CR9]\]. These factors have all been associated with retrograde flow of both transfer media and the embryo toward the fallopian tubes. Many suggestions have been made regarding optimal transfer location within the endometrium, ranging from 5 to 20 mm from the fundal surface, while others recommend "mid-cavity" location to avoid proximity to the fallopian tubes \[[@CR17]--[@CR19]\].

Other trends identified in our systematic review include \>1 embryo transferred (reported in 79 % of cases) and a large number of heterotopic abdominal pregnancy (reported in 46 % of cases). Multiple embryo transfer has always been associated with increased risk of EP with transfer of two or less embryos carrying lower risk than after three or more embryos \[[@CR20]\]. In the setting of multiple embryo transfers, identification of an intrauterine pregnancy often leads to delayed diagnosis of abdominal pregnancy in the absence of clinical symptoms. Among the heterotopic cases, 4 reported a 2 week delay in diagnosis of the abdominal ectopic from the time of suspected ectopic, and 5 cases did not identify the abdominal ectopic until beyond the 12th week of pregnancy. Unfortunately, this type of delayed diagnosis has the potential to lead to significantly morbid outcomes. In our review, four cases of viable abdominal pregnancies were identified, which is an extremely rare outcome. Three of these cases were identified at 19 weeks or beyond, and all three had attachment of the abdominal placenta to the peritoneal surface of the uterus without involvement of other abdominal organs. Placental attachment to the uterus has previously been associated with viability of abdominal pregnancies \[[@CR21]\], and with a relatively lower risk of bleeding and lower likelihood of fetal growth retardation \[[@CR22]\].

Finally, abdominal ectopic pregnancies were far more common in fresh embryo transfer (71 % of cases) than frozen embryo transfer (11 % of cases). This may be due to the fact that frozen embryo transfer has become widely used only recently, and we may begin to see higher frequency with frozen embryo transfers over time. However, several recent studies indicate that ectopic pregnancy rates are higher for fresh as compared to frozen IVF cycles \[[@CR1], [@CR6]\].

A limitation of this review is the heterogeneity of reported cases and IVF practices which encompass several decades. Further research focusing on more homogenous population may help in better characterizing this rare IVF complication.

Conclusions {#Sec6}
===========

In conclusion, ectopic pregnancy, including abdominal ectopic, is a known risk of IVF. The case reported highlights the diagnostic challenges behind this rare form of ectopic pregnancy, and the need to keep it in the differential in atypical ectopic presentations. Our systematic literature review has revealed several trends in reported cases of abdominal ectopic pregnancy after IVF including tubal factor infertility, history of tubal ectopic and tubal surgery, higher number of embryos transferred, and fresh embryo transfers. These are consistent with known risk factors for ectopic pregnancy following IVF.
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